| Myelodysplastic Syndrome studied in …STUDIED_INderived200 of 1,702show all (up to 200) |
|---|
| → studied in | NCT03187288Phase 1 · completed Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03802695Phase 1 · recruiting A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06303193Phase 1/Phase 2 · recruiting Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06904066Phase 1 · recruiting Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03494569Phase 1 · suspended Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03560752Phase 1 · active not recruiting CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04429191Phase 1 · completed JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation · condition mapped PROBABILISTIC · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06484062Phase 1 · recruiting Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06651229Phase 1 · active not recruiting A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564390Phase 2 · recruiting MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06548230Phase 1/Phase 2 · recruiting A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06618001Phase 1 · active not recruiting A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788509Phase 1 · enrolling by invitation A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820268Phase 1 · recruiting A Study of XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03661307Phase 1/Phase 2 · recruiting Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06398457early Phase 1 · recruiting Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05320198Phase 1/Phase 2 · recruiting Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839771Phase 3 · active not recruiting A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05201066Phase 2 · active not recruiting Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab. · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04935684Phase 2 · recruiting Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07346105available Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801489Phase 2 · recruiting Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 1,702 trials mapped (390 active) | — | — | De Novo Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530034Phase 1 · active not recruiting Hu8F4 in Treating Patients With Advanced Hematologic Malignancies · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03630991Phase 1 · recruiting Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04021368Phase 1 · terminated RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome · condition mapped PROBABILISTIC · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04734990Phase 1/Phase 2 · active not recruiting Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282187Phase 2 · recruiting Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04375631Phase 1 · recruiting CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06987058Phase 2 · enrolling by invitation RVU120 Rollover Study · condition mapped PROBABILISTIC · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07825207active not recruiting Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00900198recruiting Collection of Tissue Samples for Cancer Research · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816319Phase 1 · active not recruiting TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05807932Phase 1/Phase 2 · recruiting Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03849651Phase 2 · active not recruiting TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06904482Phase 2 · recruiting Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00863148Phase 2 · completed Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL) · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01541280Phase 2 · completed VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530463Phase 2 · active not recruiting Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03471260Phase 1/Phase 2 · recruiting Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03683433Phase 2 · recruiting Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771130Phase 1/Phase 2 · recruiting A Study of BGB-11417 in Participants With Myeloid Malignancies · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06765876early Phase 1 · active not recruiting CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06846606Phase 1 · recruiting Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819396Phase 2 · not yet recruiting Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05641259Phase 1 · recruiting A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05875805NA · recruiting A Telehealth Advance Care Planning Intervention · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05884333Phase 2 · recruiting Cord Blood Transplant in Adults With Blood Cancers · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06566742Phase 2 · recruiting A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia. · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06616636Phase 1 · recruiting A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome) · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06956755recruiting Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03953898Phase 2 · active not recruiting Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05589896Phase 1/Phase 2 · active not recruiting A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06680661Phase 2 · suspended ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06704152Phase 1/Phase 2 · terminated BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07710781NA · not yet recruiting Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814170NA · active not recruiting A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In Greece · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01522976Phase 2 · active not recruiting Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890329Phase 1 · active not recruiting Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04227847Phase 1 · active not recruiting A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06439199recruiting Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06888323Phase 1 · suspended Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07153497Phase 2 · not yet recruiting Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy) · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796620Phase 1/Phase 2 · not yet recruiting Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNI · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03383575Phase 2 · recruiting Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04655755Phase 1/Phase 2 · active not recruiting Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05010122Phase 1/Phase 2 · recruiting ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07805746not yet recruiting Peri-graft Cytokine Profile: Influence of Hematologic Disease and Donor Type · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04635384active not recruiting Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00843882Phase 3 · active not recruiting Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07025824Phase 2 · recruiting Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07183878NA · recruiting Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study) · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07249346Phase 2 · recruiting Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07347418Phase 1 · recruiting CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04262843Phase 2 · active not recruiting Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01885689Phase 2 · active not recruiting Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07561385not yet recruiting Dresden MDS Registry With an Accompanying Biomaterial Collection · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02494167Phase 1 · completed Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM) · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06717958Phase 2 · recruiting Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04493164Phase 2 · recruiting CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04726241Phase 1/Phase 2 · recruiting The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06247787Phase 1 · recruiting A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Childhood Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06533761Phase 1 · recruiting Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06499285Phase 3 · recruiting A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07573111Phase 1 · recruiting Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07779031Phase 1/Phase 2 · active not recruiting A Single-Arm, Open Phase I Clinical Study of Selinexor in Combination With Azacitidine for the Treatment of High-Risk AML/MDS Patients After Allo-HSCT · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07780565Phase 1 · not yet recruiting Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02392572Phase 1/Phase 2 · terminated ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05796570Phase 2 · active not recruiting A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07582172Phase 2 · recruiting Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02521493Phase 3 · active not recruiting Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04898790NA · recruiting Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05600894Phase 2 · active not recruiting Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399640Phase 1 · recruiting Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06656494Phase 1 · recruiting ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07565220Phase 1 · recruiting Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06001385Phase 2 · active not recruiting HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302776Phase 1 · recruiting TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07387354Phase 1/Phase 2 · withdrawn Pacritinib With Aza for Upfront Myelodysplastic Syndrome · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04013685Phase 1 · active not recruiting Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04173533Phase 3 · completed Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04537871active not recruiting Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05150561active not recruiting Muscle Dysfunction in Patients With Haematological Diseases · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07761533Phase 1/Phase 2 · recruiting PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01728402enrolling by invitation Pathogenesis of Hematologic Malignancies · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02732184Phase 1 · completed A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07469592NA · recruiting eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07763054recruiting Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02942290Phase 1 · completed A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS) · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03680677recruiting Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05444348NA · recruiting Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT) · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05968963NA · completed Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04708054Phase 2/Phase 3 · recruiting Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04827719Phase 2 · completed BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05457010Phase 1 · active not recruiting Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06529731Phase 2 · recruiting Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07758218Phase 1 · not yet recruiting Allogeneic iNKT Cell Therapy (agenT-797) After SCT · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00935090active not recruiting 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03503409Phase 2 · active not recruiting IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03744390Phase 2 · active not recruiting IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05308264Phase 1/Phase 2 · recruiting Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS) · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06492707Phase 1 · suspended DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse After Hematopoietic Cell Transplantation, the DR. DREAM Trial · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392353Phase 1/Phase 2 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092451Phase 1/Phase 2 · recruiting Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07752121not yet recruiting First-Line Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02861417Phase 2 · active not recruiting Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04994808Phase 2 · terminated Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570056not yet recruiting Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance) · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04281199Phase 1 · active not recruiting TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCT · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06895538Phase 2/Phase 3 · recruiting Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06960993NA · recruiting Mosaic Trial for Stem Cell Transplant Recipients · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06287944Phase 1 · recruiting 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05457556Phase 3 · active not recruiting Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06021600Phase 1 · terminated A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07737769Phase 1 · not yet recruiting Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06034470Phase 1 · active not recruiting Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07735117Phase 3 · not yet recruiting Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AML · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506933Phase 2 · active not recruiting Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04093570Phase 2 · enrolling by invitation A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05362773Phase 1 · active not recruiting A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07020533Phase 1 · recruiting A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07717164not yet recruiting PRAISE-IR Versus CIBMTR Controls · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03672539Phase 2 · completed Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05350748recruiting Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05588154recruiting Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04603001Phase 1 · active not recruiting Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06013423Phase 2 · recruiting Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07719348Phase 1/Phase 2 · not yet recruiting A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03739502Phase 2 · active not recruiting A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07046078Phase 2 · recruiting Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03480360Phase 3 · completed Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00923442enrolling by invitation Biology Studies of Hematologic Cancers · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03862157Phase 1/Phase 2 · active not recruiting Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04968834recruiting Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06498973Phase 1 · recruiting Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03843528Phase 1 · active not recruiting Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03969446Phase 1 · suspended Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05400122Phase 1 · suspended Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06594445Phase 1 · recruiting HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07698080Phase 2 · not yet recruiting Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07228273Phase 2 · recruiting Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07254793Phase 1 · not yet recruiting Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03399773Phase 2 · active not recruiting Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03810196NA · recruiting CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02935361Phase 1/Phase 2 · active not recruiting Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07216443Phase 2 · recruiting Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086315Phase 1/Phase 2 · terminated First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05139004Phase 1 · active not recruiting 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805605Phase 2 · recruiting Allo HSCT Using RIC and PTCy for Hematological Diseases · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07019155recruiting Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00710892Phase 1 · active not recruiting CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01494103Phase 1 · active not recruiting Administration of Donor T Cells With the Caspase-9 Suicide Gene · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04064060Phase 3 · recruiting A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06996119Phase 1 · recruiting Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802161Phase 2 · active not recruiting Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06357182Phase 1 · recruiting Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675967recruiting Clonal Hematopoiesis Chemotherapy and Radiation Effects Study · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01137825recruiting Registry of Older Patients With Cancer · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02719574Phase 1/Phase 2 · completed Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03173248Phase 3 · active not recruiting Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06815003Phase 2 · recruiting Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07528417Phase 2 · not yet recruiting Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06802315Phase 2 · recruiting Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS) · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03314974Phase 2 · recruiting Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04869683NA · recruiting Biocollection in MyeloDysplastic Syndrome (P-MDS) · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07249476not yet recruiting Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06551584Phase 1 · recruiting Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07572929Phase 2 · not yet recruiting A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03128034Phase 1/Phase 2 · recruiting 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia · condition mapped ONTOLOGY_EXACT · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03670966Phase 1/Phase 2 · recruiting 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome with Excess Blasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04581512Phase 1/Phase 2 · recruiting Study to Evaluate the Safety and Tolerability of EP0042 · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03050268recruiting Familial Investigations of Childhood Cancer Predisposition · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03113643Phase 1 · recruiting SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · condition mapped CURATED_BROADER · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04024761Phase 1 · recruiting A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024994Phase 2 · completed A Study of E7820 in People With Bone Marrow (Myeloid) Cancers · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06138587Phase 1 · recruiting Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02074839Phase 1 · recruiting Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation · condition mapped ALIAS · 1,702 trials mapped (390 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |